Palla Pharma (ASX:PAL) share price rockets 30% higher. Here's why

The Palla Pharma Ltd (ASX: PAL) share price is up 30% today after the company announced a change in its manufacturing facility.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Palla Pharma Ltd (ASX: PAL) share price is among the top performers on the ASX market today. This comes after the company announced that it had received approval to change its manufacturing site to its Norway production facility.

During late afternoon trade, shares in the opiate-based pain relief medicine company are up 30.3% to 73 cents. It's worth noting that the company's shares rose to an intraday high of 82 cents in the first hour of market open.

Production facility change

The Palla Pharma share price is on the move after reporting a significant tailwind in its operations.

In today's release, Palla Pharma advised that United Kingdom's medicines regulator, MHRA, has given the green light to change the manufacturing site for its Co-Codamol tablet.

Palla Pharma's Co-Codamol products contain two painkilling ingredients, paracetamol and codeine. The tablet form product relieves short-lasting painful conditions where paracetamol alone is insufficient.

In addition to the approval, the regulator also gave the nod for the company's required marketing authorisations, as well as patient information leaflets and product packaging.

As a result, Palla Pharma immediately began producing its initial batches of the product in bulk. Once it has completed the packing process, it will move onto its sales process. The company noted that production would ramp up to meet the anticipated demand for the coming months.

The UK is the biggest market in Europe for painkiller relief tablets. Each kilogram of codeine phosphate sold as part of the approved Co-Codamol product has a higher gross margin than in active pharmaceutical ingredient form or tableted form as a contract manufacturer. This in-turn represents an increase in revenue generation for the company.

Palla Pharma revealed that it would release its full-year results on Friday, 26 February.

About the Palla Pharma share price

The Palla Pharma share price has taken investors on a rollercoaster ride in the past 12 months. The company's shares dipped to an all-time low of 45 cents in March, before storming to a 52-week high of $1.08.

At today's current share price of 72 cents, Palla Pharma is down around 15% from this time last year.

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

A man analyses stockmarket graph on his computer.
Share Market News

US stocks vs. ASX shares in FY25

Would you be surprised to learn that ASX tech shares rose faster than US tech stocks by almost 2:1?

Read more »

A smiling businessman in the city looks at his phone and punches the air in celebration of good news.
Share Gainers

Why ARB, Cleanaway, Hub24, and RPMGlobal shares are storming higher today

These shares are ending the week with a bang. But why?

Read more »

a man weraing a suit sits nervously at his laptop computer biting into his clenched hand with nerves, and perhaps fear.
Share Fallers

Why Evolution Mining, G8 Education, Lottery Corp, and Lynas shares are tumbling today

These shares are ending the week in the red. But why?

Read more »

A businessman lights up the fifth star in a lineup, indicating positive share price for a top performer
Broker Notes

Bell Potter names more of the best ASX 200 stocks to buy in July

These stocks could be best buys this month according to the broker.

Read more »

A man has a surprised and relieved expression on his face. as he raises his hands up to his face in response to the high fluctuations in the Galileo share price today
Broker Notes

Macquarie tips 55% upside for this ASX mining stock

Let's see what the broker is saying about this stock.

Read more »

Five people in an office high five each other.
Technology Shares

5 best performing ASX 200 tech shares of FY25

Some of the technology sector's biggest names led the charge in share price growth last financial year.

Read more »

A concerned man looking at his laptop.
Broker Notes

Why this broker just downgraded Pro Medicus shares

Let's see what Bell Potter is saying about this high-flying stock.

Read more »

Share Market News

5 things to watch on the ASX 200 on Friday

A good finish to the week is expected for Aussie investors.

Read more »